Parameters Cases (N=26) Controls (N=78 ) COR(95% CI) p value AOR (95% CI) pvalue
BMI <18.5 20 41 3.0 (1.1-8.3) 0.033 3.7(1.1-12.3) 0.033
≥18.5 6 37 1.0      
CD4+cell count <50 15 22 13.0(1.6-107.4) 0.018 8.7 (1.0-79.1) 0.054
51-100 4 18 4.2 (0.4-41.5) 0.216 3.3 (0.3-38.1) 0.332
101-200 6 19 6.0(0.7-54.8) 0.112 4.1(0.4-46.6) 0.200
>200 1 19 1.0      
Type of TB SPPTB 10 55 1.0      
SNPTB 3 9 1.8 (0.4-7.9) 0.419 1.8 (0.3-9.8) 0.496
EPTB 13 14 5.1 (1.8-14.0) 0.002 3.1(1.0-10.1) 0.064
Hepatitis B co-infection No 19 74 1.0      
Yes 7 4 6.8 (1.8-25.7) 0.005 6.6(1.4-31.7) 0.019
WHO stage Stage 3 13 64 1.0      
Stage 4 13 14 2.8 (1.1-6.9) 0.027 3.1(0.9-10.1) 0.064
COR: Crude Odd Ratio, AOR: Adjusted Odd ratio, CI: Confidence Interval
Table 4: Multivariate regression analysis of variables associated with anti-TB drug induced hepatotoxicity.
Goto home»